1
|
Osanloo M, Ranjbar R, Zarenezhad E. Alginate Nanoparticles Containing Cuminum cyminum and Zataria multiflora Essential Oils with Promising Anticancer and Antibacterial Effects. Int J Biomater 2024; 2024:5556838. [PMID: 38725434 PMCID: PMC11081758 DOI: 10.1155/2024/5556838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2024] [Revised: 04/15/2024] [Accepted: 04/23/2024] [Indexed: 05/12/2024] Open
Abstract
Cancer and bacterial infections are major global health concerns driving the need for innovative medicines. This study investigated alginate nanoparticles loaded with essential oils (EOs) from Cuminum cyminum and Zataria multiflora as potential drug delivery systems. The nanoparticles were comprehensively characterized using techniques such as gas chromatography-mass spectrometry (GC-MS), dynamic light scattering (DLS), zetasizer, attenuated total reflectance-Fourier transform infrared spectroscopy (ATR-FTIR), and ultraviolet-visible spectroscopy (UV-Vis). Their biological properties against two human skin cancer cell lines (A-375 and A-431) and three bacteria (Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus) were also evaluated. Alginate nanoparticles containing C. cyminum and Z. multiflora EOs exhibited sizes of 160 ± 8 nm and 151 ± 10 nm, respectively. Their zeta potentials and encapsulation efficiencies were -18 ± 1 mV and 79 ± 4%, as well as -27 ± 2 mV and 86 ± 5%, respectively. The IC50 values against the tested cell lines and bacteria revealed superior efficacy for nanoparticles containing Z. multiflora EO. Considering the proper efficacy of the proposed nanoparticles, the straightforward preparation method and low cost suggest their potential for further in vivo studies.
Collapse
Affiliation(s)
- Mahmoud Osanloo
- Department of Medical Nanotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran
| | - Razieh Ranjbar
- Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa, Iran
| | - Elham Zarenezhad
- Noncommunicable Disease Research Center, Fasa University of Medical Sciences, Fasa, Iran
| |
Collapse
|
2
|
Choi S, Yoo S, Jeon M, Park S, Choi Y, An J, Jeon S, Lee M, Yun JH, Park JW, Kim I. SPATA20 deficiency enhances the metastatic and angiogenic potential of cancer cells by promoting HIF-1α synthesis. Am J Cancer Res 2024; 14:727-743. [PMID: 38455399 PMCID: PMC10915324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2023] [Accepted: 02/05/2024] [Indexed: 03/09/2024] Open
Abstract
Hypoxia-inducible factors (HIFs) regulate cellular oxygen balance and play a central role in cancer metastasis and angiogenesis. Despite extensive research on HIFs, successful therapeutic strategies remain limited due to the intricate nature of their regulation. In this study, we identified SPATA20, a relatively understudied protein with a thioredoxin-like domain, as an upstream regulator of HIF-1α. Depleting SPATA20 induced HIF-1α expression, suggesting a tumor-suppressive role for SPATA20 in cancer cells. SPATA20 depletion increased HIF-1α protein levels and transcriptional activity without affecting its degradation. It appears that SPATA20 inhibits the de novo synthesis of HIF-1α, possibly by repressing the cap-dependent translation process involving AKT phosphorylation. Additionally, depletion of SPATA20 promoted cancer cell migration and invasion, which can be reversed by pharmacological inhibition of HIF-1α. Clinical data analysis revealed an inverse correlation between SPATA20 expression and colorectal cancer progression, providing evidence of its role as a potential biomarker. Utilizing SPATA20 as an indicator for HIF-1α-targeting therapy may be an attractive strategy for treating patients with hypoxia-driven cancers. In conclusion, this study demonstrates that SPATA20 deficiency promotes cancer progression by activating the HIF-1α signaling pathway.
Collapse
Affiliation(s)
- Sanga Choi
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| | - Seongkyeong Yoo
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| | - Miyeon Jeon
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| | - Soohyun Park
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| | - Yunsup Choi
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| | - Jiyeon An
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| | - Sungmi Jeon
- Department of Plastic and Reconstructive Surgery, Seoul National University Hospital, Seoul National University College of MedicineSeoul 03080, South Korea
| | - Mingyu Lee
- Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital and Department of Medicine, Harvard Medical SchoolBoston, MA 02115, USA
| | - Jang-Hyuk Yun
- College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National UniversityChuncheon 24341, South Korea
| | - Jong-Wan Park
- Department of Pharmacology, Seoul National University College of MedicineSeoul 03080, South Korea
| | - Iljin Kim
- Department of Pharmacology and Program in Biomedical Science and Engineering, Inha University College of MedicineIncheon 22212, South Korea
- Research Center for Controlling Intercellular Communication, Inha University College of MedicineIncheon 22212, South Korea
| |
Collapse
|
3
|
Georgescu SR, Tocut SM, Matei C, Ene CD, Nicolae I, Tampa M. A Panel of Potential Serum Markers Related to Angiogenesis, Antioxidant Defense and Hypoxia for Differentiating Cutaneous Squamous Cell Carcinomas from Actinic Keratoses. J Pers Med 2024; 14:103. [PMID: 38248804 PMCID: PMC10820834 DOI: 10.3390/jpm14010103] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2023] [Revised: 01/15/2024] [Accepted: 01/16/2024] [Indexed: 01/23/2024] Open
Abstract
Cutaneous squamous cell carcinoma (cSCC) arising from the malignant proliferation of epidermal keratinocytes is the second most common skin cancer. Actinic keratosis (AK), which is considered cSCC in situ, may progress into invasive tumors. Currently, there are no serum markers that can differentiate cSCC from AK. The aim of our study was to assess angiogenesis and oxidative stress in patients with cSCC and patients with AK and find reliable serum markers useful in the diagnosis of cSCC. We have determined the serum levels of a group of proangiogenic factors (MMP-2, MMP-9, VEGF, FGF2), the total antioxidative status/capacity (TAS/TAC), ImAnOx, a marker of oxidative stress, and HIF-1 alpha, an indicator of hypoxia. We have identified higher serum levels of MMP-2. MMP-9, VEGF, FGF2 and HIF-1 alpha and lower levels of ImAnOx in cSCC patients compared to AK patients and controls. There were no statistically significant differences between AK patients and controls. We have found positive correlations between proangiogenic markers and HIF-1 alpha and negative correlations between proangiogenic markers and ImAnOx. Our results suggest that MMP-2, MMP-9, VEGF, FGF2, ImAnOx and HIF-1 may be promising markers for differentiating AK from cSCC, and there is a link between angiogenesis, oxidative stress and hypoxia.
Collapse
Affiliation(s)
- Simona Roxana Georgescu
- Department of Dermatology, ‘Carol Davila’ University of Medicine and Pharmacy, 020021 Bucharest, Romania; (S.R.G.); (M.T.)
- Department of Dermatology, ‘Victor Babes’ Clinical Hospital for Infectious Diseases, 030303 Bucharest, Romania;
| | - Sandra Milena Tocut
- Faculty of Medicine, Tel-Aviv University, Tel Aviv 69978, Israel;
- Department of Internal Medicine, “Wolfson Medical Center”, 61 Halochamim Street, 58100 Holon, Israel
| | - Clara Matei
- Department of Dermatology, ‘Carol Davila’ University of Medicine and Pharmacy, 020021 Bucharest, Romania; (S.R.G.); (M.T.)
| | - Corina Daniela Ene
- Department of Nephrology, ‘Carol Davila’ Nephrology Hospital, 010731 Bucharest, Romania
- Departments of Nephrology, ‘Carol Davila’ University of Medicine and Pharmacy, 020021 Bucharest, Romania
| | - Ilinca Nicolae
- Department of Dermatology, ‘Victor Babes’ Clinical Hospital for Infectious Diseases, 030303 Bucharest, Romania;
| | - Mircea Tampa
- Department of Dermatology, ‘Carol Davila’ University of Medicine and Pharmacy, 020021 Bucharest, Romania; (S.R.G.); (M.T.)
- Department of Dermatology, ‘Victor Babes’ Clinical Hospital for Infectious Diseases, 030303 Bucharest, Romania;
| |
Collapse
|
4
|
Fontana GA, MacArthur MR, Rotankova N, Di Filippo M, Beer HD, Gahlon HL. The mitochondrial DNA common deletion as a potential biomarker of cancer-associated fibroblasts from skin basal and squamous cell carcinomas. Sci Rep 2024; 14:553. [PMID: 38177205 PMCID: PMC10766618 DOI: 10.1038/s41598-023-50213-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2023] [Accepted: 12/16/2023] [Indexed: 01/06/2024] Open
Abstract
Cancer-associated fibroblasts (CAFs) are components of the tumor microenvironment and represent appealing therapeutic targets for translational studies. Conventional protein-based biomarkers for CAFs have been reported to be limited in their specificity, rendering difficult the identification of CAFs from normal fibroblasts (NFs) in clinical samples and dampening the development of CAF-targeted therapies to treat cancer. In this study, we propose the mitochondrial RNA and the mitochondrial DNA (mtDNA) common deletion (CD) as novel indicators of CAF identity. We found that cancer-activation correlated with decreased levels of the mtDNA CD, a condition not due to altered mitochondria count or cellular redox state, but potentially linked to the generalized overexpression of mtDNA maintenance genes in CAFs. Decreased mtDNA CD content in CAFs was associated with moderate to strong overexpression of mtDNA-encoded genes and to slightly improved mitochondrial function. We identified similar patterns of upregulation of mtDNA-encoded genes in independent single-cell RNA seq data obtained from squamous cell carcinoma (SCC) patients. By using the identified nucleic acids-based indicators, identification of CAFs from NFs could be improved, leading to potential therapeutic benefits in advancing translational and clinical studies.
Collapse
Affiliation(s)
- Gabriele A Fontana
- Department of Health Sciences and Technology, ETH Zurich, 8092, Zurich, Switzerland
- Cellvie AG, Technoparkstrasse 1, CH-8005 Zürich, Switzerland
| | - Michael R MacArthur
- Department of Health Sciences and Technology, ETH Zurich, 8092, Zurich, Switzerland
| | - Nadezhda Rotankova
- Department of Health Sciences and Technology, ETH Zurich, 8092, Zurich, Switzerland
| | - Michela Di Filippo
- Department of Dermatology, University Hospital Zurich, 8952, Schlieren, Switzerland
- Faculty of Medicine, University of Zurich, 8032, Zurich, Switzerland
| | - Hans-Dietmar Beer
- Department of Dermatology, University Hospital Zurich, 8952, Schlieren, Switzerland
- Faculty of Medicine, University of Zurich, 8032, Zurich, Switzerland
| | - Hailey L Gahlon
- Department of Health Sciences and Technology, ETH Zurich, 8092, Zurich, Switzerland.
| |
Collapse
|
5
|
Samiei M, Hassani A, Sarspy S, Komari IE, Trik M, Hassanpour F. Classification of skin cancer stages using a AHP fuzzy technique within the context of big data healthcare. J Cancer Res Clin Oncol 2023:10.1007/s00432-023-04815-x. [PMID: 37127829 DOI: 10.1007/s00432-023-04815-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2023] [Accepted: 04/23/2023] [Indexed: 05/03/2023]
Abstract
BACKGROUND AND OBJECTIVES Skin conditions in humans can be challenging to diagnose. Skin cancer manifests itself without warning. In the future, these illnesses, which have been an issue for many, will be identified and treated. With the rapid expansion of big data healthcare framework summarization and precise prediction in early stage skin cancer diagnosis, the fuzzy AHP technique produces the best results in both of these fields. Big data is a potent technology that enhances the standard of research and generates better results more rapidly. This essay gives a way to group the stages of skin cancer treatment based on this information. The combination of support vector machine multi-class classification and fuzzy selector with radial basis function-based binary migration classification of virtual machines is put through a number of experiments. The connections have been categorized. ANALYSIS METHOD These examinations have determined whether the tumors are malignant or benign and how malignant they are. The images of spots on the skin acquired from laboratory images make up the data set used for processing. We have talked about how to handle and process large datasets in the area of classification using MATLAB, like skin spot images. FINDINGS Our technique outperforms competing approaches by maintaining stability even as the size of the data set grows rapidly and with little error. In comparison to other methods, the suggested approach meets the accuracy criterion for correct classifications with a score of 90.86%. As a result, the proposed solution is viewed as a potentially useful tool for identifying mass stages and categorizing skin cancer severity.
Collapse
Affiliation(s)
- Moslem Samiei
- Department of Industrial Engineering, Islamic Azad University, Zahedan Branch, Zahedan, Iran
| | - Alireza Hassani
- Center for Physics Technologies: Acoustics, Materials and Astrophysics, Department of Applied Physics, Universitat Politècnica de València, València, Spain
| | - Sliva Sarspy
- Department of Computer Science, College of Science, Cihan University-Erbil, Erbil, Iraq
| | - Iraj Elyasi Komari
- Department of Computer Engineering, Andimeshk Branch, Islamic Azad University, Andimeshk, Iran
| | - Mohammad Trik
- Department of Computer Engineering, Boukan Branch, Islamic Azad University, Boukan, Iran.
| | - Foad Hassanpour
- Faculty of Information Technology and Computer Engineering, Azarbaijan Shahid Madani University, Tabriz, Iran
| |
Collapse
|